Brucke Financial Inc. Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Brucke Financial Inc. acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 907 shares of the healthcare conglomerate's stock, valued at approximately $492,000.

A number of other hedge funds also recently made changes to their positions in the business. ABLE Financial Group LLC boosted its stake in shares of UnitedHealth Group by 121.3% in the 4th quarter. ABLE Financial Group LLC now owns 4,121 shares of the healthcare conglomerate's stock valued at $2,084,000 after purchasing an additional 2,259 shares in the last quarter. Bernard Wealth Management Corp. acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $104,000. XY Planning Network Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter worth $377,000. Yoffe Investment Management LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $1,040,000. Finally, Capital A Wealth Management LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $559,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. Wells Fargo & Company cut their price objective on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research note on Monday, May 19th. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, Truist Financial reissued a "buy" rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $441.87.

Insider Buying and Selling

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the acquisition, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH traded down $0.58 during mid-day trading on Tuesday, reaching $294.99. The stock had a trading volume of 20,069,744 shares, compared to its average volume of 6,655,522. The stock has a 50-day simple moving average of $448.25 and a two-hundred day simple moving average of $501.48. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The stock has a market capitalization of $267.60 billion, a PE ratio of 19.03, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm earned $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.